Core Viewpoint - The company has signed an EPC contract worth $2.524 billion with the Iraq Basra Oil Company for the seawater pipeline project in Basra, Iraq, which is expected to positively impact the company's revenue and profit over the next 4-5 years [2][3][11]. Group 1: Contract Details - Contract Type and Amount: The contract is an EPC contract valued at $2.524 billion (approximately 18.032 billion RMB) [2][5]. - Contract Duration: The project contract period is 54 months, consisting of 42 months for design, procurement, construction, and trial operation, followed by 12 months for operation maintenance and training [3][8]. - Payment Terms: Payments will be made based on progress [6]. Group 2: Project Scope and Impact - Project Scope: The project involves the construction of seawater treatment facilities, main pipelines, and associated ground facilities in Basra, Iraq [3][11]. - Impact on Company: Successful implementation of the project will strengthen the company's position in the oil and gas transportation market in Iraq and the Middle East, contributing positively to revenue and profit over the next 4-5 years [11]. Group 3: Counterparty Information - Counterparty Overview: The Basra Oil Company is a publicly listed company established under Iraqi law, primarily engaged in oil and gas exploration, development, production, processing, storage, transportation, and export [4].

Group 1: Investment and Fundraising - Hanyu Pharmaceutical plans to raise no more than 968 million yuan for the development of semaglutide and other projects [1] - Ganfeng Lithium intends to introduce investors for a capital increase of up to 2.5 billion yuan [9] Group 2: Strategic Restructuring - Pingmei Shenma Holdings is undergoing a strategic restructuring as directed by the Henan provincial government, which will not affect the company's operations significantly [2][8] - Shennong Holdings is also involved in a strategic restructuring with no change in control or significant impact on operations [7][8] Group 3: Clinical Trials and Approvals - XinNuoWei's subsidiary received approval for clinical trials of a drug for treating mild Alzheimer's disease, marking a significant milestone in the development of biosimilar drugs [3] - Tainkang's subsidiary has received approval for clinical trials of CKBA cream for rosacea, a first-class innovative drug in China [4] - Baili Tianheng's drug, iza-bren, has been included in the list of breakthrough therapies, indicating its potential in treating advanced urinary tract cancer [5] Group 4: Contracts and Projects - Zhongyou Engineering signed an EPC contract worth 2.524 billion USD for a seawater pipeline project in Iraq, expected to positively impact future revenues [6]

Core Points - China Petroleum Engineering announced the signing of an EPC contract with Iraq's Basra Oil Company for a seawater pipeline project in Basra Province, with a contract value of $2.524 billion (approximately 18.032 billion RMB at the exchange rate on the project award date) [2] Company Summary - The contract is awarded to China Petroleum Pipeline Engineering Company, a wholly-owned subsidiary of China Petroleum Engineering [2] - The project signifies a strategic move for the company in expanding its international operations, particularly in the Middle East region [2] Industry Summary - The signing of the contract reflects ongoing investment and development in Iraq's oil infrastructure, indicating potential growth opportunities in the region [2] - The project aligns with the broader trend of increasing demand for oil and gas infrastructure in emerging markets [2]

Group 1 - China National Petroleum Engineering announced that its wholly-owned subsidiary signed an EPC contract worth $2.524 billion for a seawater pipeline project in Iraq, with a duration of 54 months, expected to positively impact revenue and profit over the next 4-5 years [1] - Pingmei Shenma Group is undergoing a strategic restructuring as directed by the Henan provincial government, which will not significantly affect the company's operations or control [2] - Saisir has received approval from the China Securities Regulatory Commission for the issuance of H-shares, with plans to issue up to 331,477,235 shares [3] Group 2 - Baili Tianheng's drug, iza-bren, has been included in the list of breakthrough therapies for treating advanced or metastatic urothelial carcinoma, marking a significant milestone in its clinical development [4] - Tainkang's subsidiary has received approval for clinical trials of CKBA cream for treating rosacea, a first-class innovative drug in China, addressing an unmet clinical need [6] - Xinnowei's subsidiary has received approval for clinical trials of a biosimilar drug for Alzheimer's disease, being the first of its kind in China to obtain such approval [7][8] Group 3 - Jihong Co. expects a net profit of between 209 million to 222 million yuan for the first three quarters, representing a year-on-year increase of 55% to 65% [9] - Various companies, including Borui Pharmaceutical and Qibin Group, have announced share buyback plans for employee stock ownership or incentive programs [10]

Core Viewpoint - China National Petroleum Engineering Co., Ltd. (referred to as "the company") has signed an EPC contract worth $2.524 billion (approximately 18.032 billion RMB) with Basra Oil Company (referred to as "BOC") for the seawater pipeline project in Basra, Iraq [1] Summary by Relevant Sections Contract Details - The contract duration is 54 months, which includes 42 months for design, procurement, construction, and trial operation, followed by 12 months for operation maintenance and training [1] - The contract amount is significant, indicating a major project for the company [1] Financial Impact - The execution of the contract will not have a significant impact on the company's total assets, net assets, and net profit for the current year [1] - However, the long-term nature of the contract is expected to positively influence the company's operating revenue and total profit over the next 4-5 years [1]

Group 1 - Company announced that its wholly-owned subsidiary, China Petroleum Pipeline Engineering Co., Ltd., signed an EPC contract with Iraq's Basra Oil Company for the seawater pipeline project in Basra Province, with a contract value of $2.524 billion (approximately 18.032 billion RMB) [1] - The project contract duration is 54 months, which includes 42 months for design, procurement, construction, and trial operation, followed by 12 months for operation maintenance and training [1] - The execution of this contract will not have a significant impact on the company's total assets, net assets, and net profit for the current year, but it is expected to positively influence the company's revenue and profit totals over the next 4-5 years [1]

Core Viewpoint - China Petroleum Engineering Corporation (中油工程) has signed an EPC contract worth $2.524 billion with Iraq's Basra Oil Company for the seawater pipeline project in Basra Province [1] Group 1: Company Information - The contract was signed by China Petroleum Pipeline Bureau Engineering Co., Ltd., a wholly-owned subsidiary of China Petroleum Engineering Corporation [1] - The contract amount is approximately 180.32 billion RMB based on the exchange rate on the project award date [1] Group 2: Industry Context - The project involves the construction of a seawater transportation pipeline in Iraq, indicating ongoing infrastructure development in the oil sector [1]

关于子公司中标项目签署合同的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码：600339 证券简称：中油工程 公告编号：临 2025-054 中国石油集团工程股份有限公司 重要提示： 1. 合同类型及金额：公司全资子公司中国石油管道局工程有限公司（以下简称 "管道局工程公司"）近日与伊拉克巴士拉石油公司（以下简称"BOC"）就伊拉克巴 士拉省海水输送管道总包项目（以下简称"伊拉克海水管道项目"）签署 EPC 承包合 同，合同金额 25.24 亿美元（以项目授标日汇率折算约 180.32 亿元人民币）。 2. 合同履行期限：项目合同期为 54 个月（设计采购施工试运阶段 42 个月+运行 维护培训阶段 12 个月）。 3. 对上市公司当期业绩的影响：该合同履行对公司本年度的资产总额、净资产和 净利润等不构成重大影响。由于合同履行期较长，该合同实施后将对公司未来 4-5 年 的营业收入和利润总额产生一定积极影响。 4. 特别风险提示：在合同履行过程中如果遇到市场、经济、政治等不可预计的或 不可抗力等因素，有可 ...

Core Viewpoint - The company has signed an EPC contract worth $2.524 billion with Iraq's Basra Oil Company for a seawater pipeline project, which will positively impact future revenues and profits over the next 4-5 years [1] Financial Impact - The contract amount is approximately 180.32 billion RMB based on the exchange rate at the time of project awarding [1] - The execution of this contract will not have a significant impact on the company's total assets, net assets, and net profit for the current year [1] Future Outlook - The long duration of the contract is expected to contribute positively to the company's operating income and total profit over the next 4-5 years [1]

Core Viewpoint - The company, China National Petroleum Engineering Co., Ltd. (中油工程), has signed an EPC contract worth $2.524 billion for a seawater pipeline project in Basra, Iraq, indicating a significant expansion in its international operations [1] Group 1: Contract Details - The contract was signed with the Basra Oil Company for the seawater pipeline project in Basra Province, Iraq [1] - The total contract amount is $2.524 billion, which is approximately 18.032 billion RMB based on the exchange rate at the time of project awarding [1] - The duration of the project contract is set for 54 months [1]